Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History TMDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics TMDX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

TransMedics Group Inc

TMDX
Current price
113.32 USD -4.05 USD (-3.45%)
Last closed 115.68 USD
ISIN US89377M1099
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 4 221 781 504 USD
Yield for 12 month -24.06 %
1Y
3Y
5Y
10Y
15Y
TMDX
21.11.2021 - 28.11.2021

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. Address: 200 Minuteman Road, Andover, MA, United States, 01810

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

135.86 USD

P/E Ratio

87.87

Dividend Yield

Financials TMDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures TMDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+441 540 000 USD

Last Year

+241 623 000 USD

Current Quarter

+143 537 000 USD

Last Quarter

+121 624 000 USD

Current Year

+262 081 000 USD

Last Year

+154 093 000 USD

Current Quarter

+88 228 000 USD

Last Quarter

+72 013 000 USD
EBITDA 74 111 000 USD
Operating Margin TTM 19.12 %
Price to Earnings 87.87
Return On Assets TTM 4.21 %
PEG Ratio
Return On Equity TTM 22.99 %
Wall Street Target Price 135.86 USD
Revenue TTM 488 227 008 USD
Book Value 7.87 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 48.20 %
Dividend Yield
Gross Profit TTM 290 347 008 USD
Earnings per share 1.42 USD
Diluted Eps TTM 1.42 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 100.60 %
Profit Margin 10.03 %

Stock Valuation TMDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 87.87
Forward PE 68.49
Enterprise Value Revenue 9.19
Price Sales TTM 8.65
Enterprise Value EBITDA 52.20
Price Book MRQ 16.06

Technical Indicators TMDX

For 52 Weeks

55.00 USD 177.37 USD
50 Day MA 122.99 USD
Shares Short Prior Month 7 860 937
200 Day MA 94.35 USD
Short Ratio 9.46
Shares Short 8 044 092
Short Percent 40.14 %